Synthesis and In silico Docking Study of Some New Quinazolin-2,4-diones Targeting COVID-19 (SARS-Cov-2) Main Protease: A Search for Anti-Covid19 Drug Candidates - Egyptian Knowledge Bank - troweb

269645

Synthesis and In silico Docking Study of Some New Quinazolin-2,4-diones Targeting COVID-19 (SARS-Cov-2) Main Protease: A Search for Anti-Covid19 Drug Candidates

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Protein-Ligand In- Silico Molecular Docking Model for Discovering Potential Drugs of COVID-19

Article

Synthesis, Molecular Docking and Biological Evaluation of Some Novel Heterocyclic Derivatives

Article

Synthesis, Anticancer Activity and Molecular Docking Study of some New Thiazolo[2, 3-a]Pyrimidinedione-Based Heterocyclic Compounds

Article

Synthesis, Biological Evaluation and Molecular Docking Studies of Newly Synthesized 4- Amino Quinazoline Derivatives as Potential Multitarget Anticancer Agents.

Article

Synthesis, Docking and Biological Evaluation of 2,4- Disubstituted Quinazolines With Multi-Target Activities as Anti-cancer and Antimicrobial Agents

Article

Synthesis, Antimicrobial Evaluation and Docking Study of Novel Heterocyclic Compounds Bearing a Biologically Active Sulfonamide Moiety

Article

Synthesis and in silico studies of novel pyrazole-based anti-MERS-CoV agents

Article

Investigation of COVID-19 By Theoretical Docking of Medicines With Two Proteins

Article

DESIGN, SYNTHESIS, MOLECULAR DOCKING AND BIOLOGICAL EVALUATION OF SOME NOVEL QUINAZOLIN-4(3H)-ONE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS

Article

Design Synthesis and Characterization of Novel Quinazolin-4(3H)-one Derivatives with Anticipated Pharmacological Efficacy